© 2021 MJH Life Sciences and Cure Today. All rights reserved.
© 2021 MJH Life Sciences™ and Cure Today. All rights reserved.
January 23, 2018
Now that we're in an era of personalized medicine, patients should not look at statistics and immediately think that they will determine their fate, says Tom Stockwell, patient navigator at the Fibrolamellar Cancer Foundation.
Molar Pregnancy Survivor Shares Her Rare Cancer Story
Opdivo Regimen Pulled for Liver Cancer Treatment
Navigating Chronic Lymphocytic Leukemia Diagnosis and Staging
‘Treadmill of Survivorship’ With a Supportive Oncology Nurse